Using female mice, researchers find that a frequently used breast cancer treatment impairs molecular and behavioral measures of the primary biological clock found in the brain.

A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the fungal component of the human microbiome — known as the mycobiome — and risk of developing chronic disease. The findings establish previously unrecognized connections between human genetics, gut fungi and chronic disease, broadening the paradigm of human-microbe interactions in the gut to include the mycobiome. 

Phase 1/2 trial found that six months of daily growth hormone plus biweekly testosterone was safe, well-tolerated, and produced meaningful gains in men with facioscapulohumeral muscular dystrophy (FSHD).